ホーム › 膵臓がん › ニューヨーク › New York City
New York City、NYにおける膵臓がんの臨床試験
New York Cityとその周辺地域（約30マイル以内）の拠点で、膵臓がんに関する60件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
被験者募集中第1/2相
- Research Site, New York
- Research Site, New York
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
被験者募集中第3相
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
被験者募集中
- Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
被験者募集中第1相
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Icahn School of Medicine at Mount Sinai, New York
- 他2件
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
被験者募集中第2相
- Memorial Sloan Kettering Hospital, New York
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
被験者募集中第3相
- Columbia University Irving Medical Center, New York
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
被験者募集中第1相
- Columbia University Irving Medical Center, New York
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
被験者募集中観察研究
- NYU Langone Medical Center, New York
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
被験者募集中第2/3相
- Icahn School of Medicine at Mount Sinai, New York
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
被験者募集中第3相
- Laura and Issac Perlmutter Cancer Center at NYU Langone-Ambulatory Care Center, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center, New York
- 他1件
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
被験者募集中第3相
- Investigative Site US031, New York
- Investigative Site US003, New York
- Investigative Site US041, New York
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
被験者募集中第3相
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
被験者募集中第1/2相
- Columbia University Medical Center, New York
- Memorial Sloan Kettering Cancer Center Main Campus, New York
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
被験者募集中第1/2相
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
被験者募集中第1/2相
- NYU Langone Health Perlmutter Cancer Center, New York
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
被験者募集中第1相
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
被験者募集中第2相
- Local Institution - 0170, New York
- Memorial Sloan Kettering Cancer Center, New York
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
被験者募集中観察研究
- Manhattan Eye Ear and Throat Hospital, New York
- Lenox Hill Hospital, New York
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
被験者募集中第1相
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
被験者募集中第2相
- NYU-Manhattan, New York
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
被験者募集中第1相
- David H Koch, Memorial Sloan Kettering Cancer Center, New York
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
被験者募集中
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
被験者募集中第1/2相
- Mount Sinai Hospital, New York
- NYP/Weill Cornell Medical Center, New York
Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
被験者募集中
- NYU Langone Health, New York
- Lenox hill Hospital, New York
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
被験者募集中第1相
- New York Cancer & Blood Specialists, New York
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
被験者募集中第3相
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Mount Sinai West, New York
- Mount Sinai Hospital, New York
- 他2件
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
被験者募集中観察研究健康なボランティア歓迎
- Memorial Sloan - Kettering Cancer Center, New York
- Memorial Sloan Kettering Basking Ridge (All protocol activities), New York
- Weill Cornell Medical Center, New York
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
被験者募集中第1相
- Investigative Site #103, New York
- Investigative Site #106, New York
Pancreatic Cancer Early Detection Consortium
被験者募集中観察研究健康なボランティア歓迎
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine At Mount Sinai, New York
- Columbia University Irving Medical Center, New York
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
被験者募集中第2相
- NYU Langone Health Perlmutter Cancer Center, New York
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center, New York
A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening
被験者募集中観察研究
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
被験者募集中第1/2相
- NYU Langone Medical Center, New York
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
被験者募集中第1相
- Research Site, New York
- Research Site, New York
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
被験者募集中第1相
- NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
被験者募集中第1/2相
- Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan-Kettering Cancer Center, New York
- Columbia University, New York
Brodalumab in the Treatment of Immune-Related Adverse Events
被験者募集中第1相
- Columbia University Irving Medical Center, New York
Pancreatic Cancer Genetics
被験者募集中観察研究
- Columbia University Medical Center, New York
A Study of MGC028 in Participants With Advanced Solid Tumors
被験者募集中第1相
- Icahn School of Medicine at Mt. Sinai, New York
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
被験者募集中第1/2相
- Laura & Isaac Perlmutter Cancer Center at NYU Langone, New York
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
被験者募集中観察研究健康なボランティア歓迎
- Columbia University Medical Center, New York
A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer
被験者募集中第1/2相
- Columbia University Irving Medical Center, New York
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
被験者募集中第2相
- Ohio State University-Telemedicine, New York
Pancreas Registry and High Risk Registry
被験者募集中観察研究
- Mount Sinai West, New York
- Icahn School of Medicine at Mount Sinai, New York
Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer
被験者募集中観察研究健康なボランティア歓迎
- Memorial Sloan Kettering Cancer Center, New York
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center, New York
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
被験者募集中観察研究
- Manhattan Eye Ear and Throat Hospital, New York
- Lenox Hill Hospital, New York
A Study of Multiparametric Ultrasound Imaging Methods
被験者募集中健康なボランティア歓迎
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
被験者募集中第1/2相
- Weill Cornell Medicine, Cornell University (site 126), New York
EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)
被験者募集中第1相
- Tisch Hospital, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, New York
The Cancer of the Pancreas Screening-5 CAPS5)Study
被験者募集中第3相
- NYU Langone Medical Center, New York
- Columbia University Medical Center, New York
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
被験者募集中第1相
- Exelixis Clinical Site #5, New York
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
被験者募集中観察研究
- Icahn School of Medicine at Mount Sinai, New York
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
被験者募集中第1相
- Memorial Sloan Kettering, New York
- Columbia University Herbert Irving Comprehensive Cancer Center, New York
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma
被験者募集中第2相
- Columbia University Medical Center, New York
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
被験者募集中第2/3相
- Columbia University Medical Center, New York
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
被験者募集中第2相
- Icahn School of Medicine at Mount Sinai, New York
他の都市における膵臓がんの試験
- Houston, TX61件の研究
- Boston, MA43件の研究
- Nashville, TN39件の研究
- Los Angeles, CA35件の研究
- St. Louis, MO33件の研究
- Arlington, VA33件の研究
- Baltimore, MD31件の研究
- San Antonio, TX31件の研究
- Philadelphia, PA26件の研究
- Tampa, FL26件の研究
- Durham, NC24件の研究
- San Diego, CA24件の研究
New York Cityにおける他の研究
- 乳がん136件の研究
- 非小細胞肺癌121件の研究
- がん（全種類）109件の研究
- 前立腺がん103件の研究
- 転移性癌93件の研究
- 大腸癌78件の研究
- 卵巣がん69件の研究
- 肺がん60件の研究
- 多発性骨髄腫60件の研究
- 子宮内膜がん52件の研究
- 急性骨髄性白血病51件の研究
- 心不全51件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。